KIGAWA Junzo 紀川純三

… Alternative Names

起川純三キガワジュンゾウ

Less

Researcher Number	00177784
Other IDs
Affiliation (based on the past Project Information) *help	2012 – 2015: 鳥取大学, 医学部附属病院, 教授 2007: Tottori University, Hospital, Professor 2005 – 2006: 鳥取大学, 医学部, 助教授 2004: 国立大学法人鳥取大学, 医学部, 助教授 1998 – 2003: 鳥取大学, 医学部, 助教授 1994 – 1997: 鳥取大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Obstetrics and gynecology / Obstetrics and gynecology Except Principal Investigator Obstetrics and gynecology / Obstetrics and gynecology
Keywords	Principal Investigator p53 / 遺伝子治療 / 卵巣癌 / アポトーシス / gene therapy / ovarian cancer / p53遺伝子 / genetic diagnosis / 抗癌剤 / 遺伝子 … More / 個別化治療 / 上皮性卵巣癌 / 遺伝子診断 / lperitonitis carcinomatosa model / apoptosis / P53 gene / 癌性腹膜炎 / telomere / gene-therapy / ovarian cancer apoptosis / telomerae / p53gene / 化学療法 / 遺伝子導入 / テロメラーゼ / テロメア / p53遺伝子導入 / p53 gene / chemoresistance / 遺伝子変異 / 薬剤耐性 … More Except Principal Investigator IL-8 / アポトーシス / 卵巣癌 / p53 / 子宮内膜癌 / Chemoresponse / Gene therapy / Carcinoma / 薬剤反応性 / 遺伝子 / 癌 / KGN cells / granulosa cell / estrogen / leptin / KGN細胞 / 顆粒膜細胞 / エストロゲン / レプチン / Cisplatin / Chemosensitivity / Apoptosis / Ovarian cancer / シスプラチン / 抗癌剤耐性 / Paracrine effect / Cancer growth / Microvessel density / Stromal cells / Interleukin-8 / Tumor necrosis factor a / Angiogenic factor / Endometrial cancer / TNFα / 細胞増殖 / 子宮内膜症 / 子宮内膜 / パラクリン作用 / 癌増殖 / 微小血管数 / 間質細胞 / インターロイキン-8(IL-8) / 腫瘍壊死因子α(TNFα) / 血管新生因子 / ovarian cancer / cicplatin-resistance / topoisomerase / apoptosis / シスプラチン耐性 / トポイソメラーゼ / Inhibition of angiogenesis / Growth inhibition / Synthetic analogue of fumagillin / Medroxyprogesterone acetate / Anti-tumor effect / Nood mouse model / Endometrial Cancer / 併用療法 / プロゲスチン / 血管新生阻害剤 / 血管新生阻害 / 増殖抑制 / フマギリン誘導体 / 酢酸メドロキシプロゲステロン / 抗腫瘍作用 / ヌードマウス系 / mTOR阻害剤 / PI3K阻害剤 / PIK3CA / 明細胞癌 / PI3K / 明細胞腺癌 / FGFR2 / 卵巣明細胞腺癌 Less

Development of combination therapy using PI3K inhibitor and its predictive biomarker in clear cell carcinoma of the ovary
- Principal Investigator
  
  Oishi Tetsuro
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Adenovirus type 5 EIA gene therapy for ovarian carcinoma
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2005 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Order made gene therapy for epithelial ovarian cancer on biological behaviorPrincipal Investigator
- Principal Investigator
  
  KIGAWA Junzou
- Project Period (FY)
  2004 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Role of leptin and interleukin-8 in human ovary
- Principal Investigator
  
  IRIE Takashi
- Project Period (FY)
  2001 – 2003
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University School of Medicine
Gene therapy enhances chemotherapy induced apoptosis in a peritonitis carcinomatosa model with ovarian cancerPrincipal Investigator
- Principal Investigator
  
  KIGAWA Junzo
- Project Period (FY)
  2000 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University School of Medicine
Chemoresistance and apoptotic pathway in ovarian cancer.
- Principal Investigator
  
  KANAMORI Yasunobu, 皆川幸久
- Project Period (FY)
  1998 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University School of Medicine
Telomerase activity and p53-induced apoptosisPrincipal Investigator
- Principal Investigator
  
  KIGAWA Junzo
- Project Period (FY)
  1997 – 1999
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Interleukin-8 is a possible angiogenic factor in endometrial cancer
- Principal Investigator
  
  TERAKAWA Naoki
- Project Period (FY)
  1996 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University (School of Medicine)
p53-based gene therapy of ovarian cancer with chemo-resistancePrincipal Investigator
- Principal Investigator
  
  KIGAWA Junzo
- Project Period (FY)
  1995 – 1996
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University, Faculty of Medicine
Overcoming cisplatin-resistance in ovarian cancer through induction of apoptosis by anticancer agents
- Principal Investigator
  
  MINAGAWA Yukihisa
- Project Period (FY)
  1995 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University (School of Medicine)
Effects of medroxyprogesterone acetate and synthetic analogue of fumagillin on endometrial cancer
- Principal Investigator
  
  TERAKAWA Naoki
- Project Period (FY)
  1994 – 1995
- Research Category
  
  Grant-in-Aid for General Scientific Research (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University, Faculty of Medicine

All 2015 2014 2013 2006

All Journal Article Presentation

[Journal Article] Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and nay be a novel therapeutic approach.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Taniguchi F, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 25 Issue: 4 Pages: 570-576
- DOI
  10.1097/igc.0000000000000414
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24592517, KAKENHI-PROJECT-26462490
[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T
- Journal Title
  
  Int J Clin Oncol
  
  Volume: 20 Issue: 5 Pages: 967-973
- DOI
  10.1007/s10147-015-0811-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462594
[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Shoji T, Fujiwara H, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Journal Title
  
  Int J Clin Oncol
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] The PI3K/mTOR dual Inhibitor NVP-BEZ235 Reduces Growth of Ovarian Clear Cell Carcinoma.2014
- Author(s)
  Oishi T, Itamochi H, Kudoh A, Nonaka M, Kato M, Nishimura M, Oumi N, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Oncology Report
  
  Volume: 32
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462594
[Journal Article] Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.2014
- Author(s)
  Itamochi H, Nishimura M, Oumi N, Kato M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Kudoh A, Kigawa J, Harada H.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 1 Pages: 61-69
- DOI
  10.1097/igc.0000000000000014
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Dual inhibition of phosphatidylinositol 3’-kinase and mammalian target of rapamycin using NVP-BEZ235 as a vovel therapeutic approach for mucinous adenocarcinoma of the ovary.2014
- Author(s)
  Kudoh A, Oishi T, Itamochi H, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 3 Pages: 444-453
- DOI
  10.1097/igc.0000000000000091
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.2013
- Author(s)
  Itamochi H., Kato M., Nishimura M., Oumi N., Oishi T., Shimada M., Sato S., Naniwa J., Sato S., Nonaka M., Kudoh A., Terakawa N., Kigawa J., and Harada T.
- Journal Title
  
  Human Cell
  
  Volume: 26 Issue: 3 Pages: 121-127
- DOI
  10.1007/s13577-013-0062-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592517
[Presentation] 卵巣明細胞腺癌におけるphosphatidylinositide 3-kinase (PI3K) - Akt経路およびARID1A蛋白発現と臨床的意義の検討2015
- Author(s)
  大石徹郎、板持広明、近江奈央、庄子忠宏、嵯峨泰、藤原寛行、島田宗昭、杉山徹、鈴木光明、紀川純三、原田省
- Organizer
  第67回日本産科婦人科学会学術講演会
- Place of Presentation
  神奈川県横浜市
- Year and Date
  2015-04-09
- Data Source
  KAKENHI-PROJECT-25462594
[Presentation] 卵巣明細胞腺癌におけるPI3K-Akt 経路およびARID1A 蛋白発現と臨床的意義の検討2015
- Author(s)
  大石徹郎、板持広明、庄子忠宏、嵯峨泰、藤原寛行、島田宗昭、杉山徹、鈴木光明、紀川純三、原田省
- Organizer
  第74回日本癌学会
- Place of Presentation
  愛知県名古屋市
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-25462594
[Presentation] Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Taniguchi F, Shoji T, Saga Y, Fujiwara H, Shimada M, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Organizer
  106th Annual Meeting of the American Association for Cancer Research
- Place of Presentation
  フィラデルフィア（アメリカ合衆国）
- Year and Date
  2015-04-21
- Data Source
  KAKENHI-PROJECT-24592517
[Presentation] Feasibility study comparing docetaxel-cisplatin versus docetaxel-carboplatin as first-line chemotherapy for ovarian cancer2006
- Author(s)
  Junzo, Kigawa
- Organizer
  42th Annual Meeting of American Society of Clinical Oncology
- Place of Presentation
  Atlanta, USA
- Year and Date
  2006-06-03
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] Feasibility study comparing docetaxel-cisplatin versus docetaxel-carboplatin as first-line chemotherapy for ovarian cancer.2006
- Author(s)
  Junzo Kigawa
- Organizer
  42th Annual meeting of American Society of Clinical Oncology
- Place of Presentation
  Atlanta
- Year and Date
  2006-06-03
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591737

1. TERAKAWA Naoki (90163906)

# of Collaborated Projects: 9 results

# of Collaborated Products: 0 results
2. MINAGAWA Yukihisa (70190692)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
3. KANAMORI Yasunobu (70283984)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
4. ITAMOCHI Hiroaki (20314601)

# of Collaborated Projects: 5 results

# of Collaborated Products: 10 results
5. HARADA Tasuku (40218649)

# of Collaborated Projects: 4 results

# of Collaborated Products: 10 results
6. SATO Syinya (10423261)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
7. SHIMADA Muneaki (40362892)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
8. OISHI Tetsuro (80359877)

# of Collaborated Projects: 3 results

# of Collaborated Products: 10 results
9. SATO Seiya (30621007)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
10. CHIKUMI Jun (70467702)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
11. IRIE Takashi (70273894)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 石原浩 (80252865)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 高橋正国 (30379622)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. NANIWA Jun

# of Collaborated Projects: 0 results

# of Collaborated Products: 4 results

KIGAWA Junzo 紀川 純三

起川 純三 キガワ ジュンゾウ

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Order made gene therapy for epithelial ovarian cancer on biological behaviorPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Gene therapy enhances chemotherapy induced apoptosis in a peritonitis carcinomatosa model with ovarian cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Telomerase activity and p53-induced apoptosisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

p53-based gene therapy of ovarian cancer with chemo-resistancePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and nay be a novel therapeutic approach.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.2015

KIGAWA Junzo 紀川純三

起川純三キガワジュンゾウ

[Presentation] 卵巣明細胞腺癌におけるPI3K-Akt 経路およびARID1A 蛋白発現と臨床的意義の検討2015